S-1874-119
Placed on Senate Legislative Calendar under General Orders. Calendar No. 527.
Sponsored by Jeff Merkley (D-OR)
What it does
This bill would reauthorize and expand federal nursing workforce development programs under Title VIII of the Public Health Service Act through fiscal year 2031. It would increase authorized funding for nursing education programs (from $137.8 million to $184.3 million annually for Parts A–D, and from $117.1 million to $121.1 million annually for Part E), create a new nurse faculty salary supplement demonstration program (authorized at $15 million over five years), and establish a new state and regional nursing workforce data collection pilot program (up to $1.5 million per year for three years). It would also expand eligible uses of existing grants to include simulation technology, telehealth equipment, and clinical education partnerships.
Who benefits
Nursing students, particularly those in advanced practice programs (nurse practitioners, nurse-midwives, nurse anesthetists, clinical nurse specialists) who would gain access to expanded grant funding. Nursing schools and their faculty, who would benefit from salary supplements designed to close the pay gap between academic and clinical nursing positions. Patients in rural and underserved areas, who may gain access to more nurses if workforce shortages are reduced. Community health centers and nurse-managed clinics that partner with schools for clinical education. Small-population states (under 1.5 million residents), which are guaranteed at least 20% of faculty grant funds. State agencies, boards of nursing, and nonprofits that would receive data collection grants. Indirectly, the broader U.S. healthcare system, which faces a projected nursing shortage.
Who is hurt
Taxpayers who bear the cost of increased federal appropriations. Competing federal health programs that may face budget trade-offs in appropriations negotiations. Clinical healthcare employers (hospitals, clinics) who may lose experienced nurses to academic positions if faculty salaries become more competitive. Nursing schools that do not meet eligibility criteria or are not selected in competitive grant processes. Uninsured or underinsured patients, who are not directly addressed by this workforce-focused bill and may not see near-term access improvements.
Supporters argue
Supporters argue that the United States faces a severe and worsening nursing shortage — the Bureau of Labor Statistics projects over 190,000 nursing job openings annually through 2032 — and that a primary bottleneck is a lack of qualified nursing faculty, which causes schools to turn away qualified applicants. They contend that the faculty salary gap (academic nurses often earn significantly less than clinical nurses) is a documented driver of faculty shortages, and that the new demonstration program directly targets this structural problem. Supporters also argue the bill has broad bipartisan backing, with sponsors from both parties, reflecting consensus that nursing workforce capacity is a national infrastructure priority.
Opponents argue
Opponents argue that simply increasing federal appropriations and adding new grant programs does not guarantee measurable improvements in nursing workforce capacity, pointing to decades of Title VIII funding that have not resolved persistent shortages. They contend that the faculty salary supplement program, while well-intentioned, creates a three-year federal dependency with no guaranteed mechanism for schools to sustain higher salaries after the grant period ends — potentially leaving faculty in a worse position when funding lapses. Critics may also argue that the $184 million annual authorization represents a roughly 34% spending increase over prior levels without sufficient evidence that previous funding levels were used efficiently.